

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | seminiferous tubule development (GO:0072520) | 9.86726830 |
| 2 | regulation of T-helper 1 cell differentiation (GO:0045625) | 8.60283186 |
| 3 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 7.18178956 |
| 4 | positive regulation of T-helper cell differentiation (GO:0045624) | 6.04774971 |
| 5 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 5.76721115 |
| 6 | positive regulation of cAMP-mediated signaling (GO:0043950) | 5.54615894 |
| 7 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 5.48115604 |
| 8 | T-helper 1 type immune response (GO:0042088) | 5.44963693 |
| 9 | positive regulation of antigen processing and presentation (GO:0002579) | 5.38650470 |
| 10 | regulation of T-helper cell differentiation (GO:0045622) | 5.13946402 |
| 11 | positive regulation of T-helper 1 type immune response (GO:0002827) | 5.06884353 |
| 12 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 4.99434202 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.93268391 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.93268391 |
| 15 | regulation of antigen processing and presentation (GO:0002577) | 4.92037616 |
| 16 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.88073357 |
| 17 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 4.86969247 |
| 18 | sperm capacitation (GO:0048240) | 4.86690384 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 4.84696928 |
| 20 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.81940689 |
| 21 | type I interferon signaling pathway (GO:0060337) | 4.78332492 |
| 22 | cellular response to type I interferon (GO:0071357) | 4.78332492 |
| 23 | response to type I interferon (GO:0034340) | 4.70926120 |
| 24 | maintenance of gastrointestinal epithelium (GO:0030277) | 4.69598951 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.61073168 |
| 26 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.58413216 |
| 27 | regulation of T-helper 1 type immune response (GO:0002825) | 4.47995350 |
| 28 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.47461797 |
| 29 | interferon-gamma secretion (GO:0072643) | 4.42253713 |
| 30 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.38332196 |
| 31 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 4.35565776 |
| 32 | * positive regulation of interleukin-12 production (GO:0032735) | 4.34918315 |
| 33 | angiotensin maturation (GO:0002003) | 4.25471056 |
| 34 | O-glycan processing (GO:0016266) | 4.24726342 |
| 35 | * regulation of interleukin-12 production (GO:0032655) | 4.24314013 |
| 36 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 4.21739341 |
| 37 | * positive regulation of type 2 immune response (GO:0002830) | 4.17625574 |
| 38 | dendritic cell chemotaxis (GO:0002407) | 4.15424746 |
| 39 | regulation of interferon-alpha production (GO:0032647) | 4.12960631 |
| 40 | vitamin transmembrane transport (GO:0035461) | 4.05252247 |
| 41 | response to peptidoglycan (GO:0032494) | 4.00160311 |
| 42 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.97355404 |
| 43 | dendritic cell differentiation (GO:0097028) | 3.95093185 |
| 44 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.92394133 |
| 45 | positive regulation of interleukin-10 production (GO:0032733) | 3.91903587 |
| 46 | defense response to protozoan (GO:0042832) | 3.89244026 |
| 47 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.86985286 |
| 48 | lymphocyte chemotaxis (GO:0048247) | 3.82472625 |
| 49 | cellular response to interferon-gamma (GO:0071346) | 3.80703601 |
| 50 | response to interferon-gamma (GO:0034341) | 3.79220853 |
| 51 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.77953740 |
| 52 | T cell migration (GO:0072678) | 3.77738201 |
| 53 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.77612638 |
| 54 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.76215284 |
| 55 | negative regulation of protein autophosphorylation (GO:0031953) | 3.75640977 |
| 56 | NIK/NF-kappaB signaling (GO:0038061) | 3.75537919 |
| 57 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.75044197 |
| 58 | positive regulation of interferon-alpha production (GO:0032727) | 3.74593902 |
| 59 | intestinal absorption (GO:0050892) | 3.74374823 |
| 60 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.72929806 |
| 61 | glial cell proliferation (GO:0014009) | 3.72375635 |
| 62 | positive regulation of defense response to virus by host (GO:0002230) | 3.71945875 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 3.69928477 |
| 64 | cGMP-mediated signaling (GO:0019934) | 3.69619958 |
| 65 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.69564446 |
| 66 | regulation of vitamin metabolic process (GO:0030656) | 3.65117106 |
| 67 | regulation of guanylate cyclase activity (GO:0031282) | 3.64699199 |
| 68 | thyroid hormone metabolic process (GO:0042403) | 3.63699956 |
| 69 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.62640208 |
| 70 | epithelial structure maintenance (GO:0010669) | 3.62428528 |
| 71 | regulation of mononuclear cell migration (GO:0071675) | 3.61829089 |
| 72 | positive regulation of interleukin-17 production (GO:0032740) | 3.59641067 |
| 73 | hepatocyte apoptotic process (GO:0097284) | 3.57674421 |
| 74 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.57583304 |
| 75 | regulation of interleukin-1 secretion (GO:0050704) | 3.57095654 |
| 76 | macrophage activation involved in immune response (GO:0002281) | 3.56844648 |
| 77 | intestinal epithelial cell development (GO:0060576) | 3.56228818 |
| 78 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.55992271 |
| 79 | response to protozoan (GO:0001562) | 3.53647475 |
| 80 | sulfur amino acid catabolic process (GO:0000098) | 3.53587321 |
| 81 | myeloid dendritic cell differentiation (GO:0043011) | 3.51160596 |
| 82 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 3.51134715 |
| 83 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.49230815 |
| 84 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.47581437 |
| 85 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.46444742 |
| 86 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.44749469 |
| 87 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.44252771 |
| 88 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.40486315 |
| 89 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.39436998 |
| 90 | positive regulation of neutrophil migration (GO:1902624) | 3.39436998 |
| 91 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.39123735 |
| 92 | negative regulation of viral genome replication (GO:0045071) | 3.38294896 |
| 93 | cytidine metabolic process (GO:0046087) | 3.35914224 |
| 94 | cytidine catabolic process (GO:0006216) | 3.35914224 |
| 95 | cytidine deamination (GO:0009972) | 3.35914224 |
| 96 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.35789755 |
| 97 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.34154581 |
| 98 | regulation of podosome assembly (GO:0071801) | 3.33402065 |
| 99 | response to nitric oxide (GO:0071731) | 3.32153234 |
| 100 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.29494721 |
| 101 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.29494721 |
| 102 | modulation by symbiont of host immune response (GO:0052553) | 3.29494721 |
| 103 | positive regulation by symbiont of host defense response (GO:0052509) | 3.29494721 |
| 104 | modulation by symbiont of host defense response (GO:0052031) | 3.29494721 |
| 105 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.29494721 |
| 106 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.29355703 |
| 107 | regulation of growth of symbiont in host (GO:0044126) | 3.29355703 |
| 108 | negative regulation of growth of symbiont in host (GO:0044130) | 3.29355703 |
| 109 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.29355703 |
| 110 | regulation of alpha-beta T cell differentiation (GO:0046637) | 3.28897869 |
| 111 | negative regulation of interleukin-17 production (GO:0032700) | 3.25330997 |
| 112 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.23123629 |
| 113 | digestion (GO:0007586) | 3.22270922 |
| 114 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.21679627 |
| 115 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.21671071 |
| 116 | intestinal cholesterol absorption (GO:0030299) | 3.17530591 |
| 117 | * regulation of interleukin-10 production (GO:0032653) | 3.17294633 |
| 118 | defense response to virus (GO:0051607) | 3.15785667 |
| 119 | negative regulation of cell killing (GO:0031342) | 3.15646146 |
| 120 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.15646146 |
| 121 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.14137196 |
| 122 | positive regulation of interferon-beta production (GO:0032728) | 3.12518217 |
| 123 | L-serine transport (GO:0015825) | 3.10019335 |
| 124 | detection of molecule of bacterial origin (GO:0032490) | 3.09962882 |
| 125 | dendritic cell migration (GO:0036336) | 3.09319137 |
| 126 | cellular response to interferon-alpha (GO:0035457) | 3.08506999 |
| 127 | cytokine secretion (GO:0050663) | 3.08504401 |
| 128 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.07932198 |
| 129 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.05844081 |
| 130 | cellular response to lipopolysaccharide (GO:0071222) | 3.04913372 |
| 131 | actin filament depolymerization (GO:0030042) | 3.03121330 |
| 132 | negative regulation of interleukin-8 production (GO:0032717) | 3.01480550 |
| 133 | hemidesmosome assembly (GO:0031581) | 2.99650780 |
| 134 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.98200026 |
| 135 | serine transport (GO:0032329) | 2.86528635 |
| 136 | hypotonic response (GO:0006971) | 2.85254759 |
| 137 | single fertilization (GO:0007338) | 2.84449902 |
| 138 | regulation of RIG-I signaling pathway (GO:0039535) | 2.84411589 |
| 139 | response to histamine (GO:0034776) | 2.81810313 |
| 140 | regulation of viral release from host cell (GO:1902186) | 2.76590863 |
| 141 | hydrogen peroxide catabolic process (GO:0042744) | 2.75751533 |
| 142 | cell communication involved in cardiac conduction (GO:0086065) | 2.73685571 |
| 143 | digestive system process (GO:0022600) | 2.72624623 |
| 144 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.71783158 |
| 145 | transepithelial transport (GO:0070633) | 2.71389340 |
| 146 | cellular ketone body metabolic process (GO:0046950) | 2.68472113 |
| 147 | synaptic transmission, dopaminergic (GO:0001963) | 2.68460302 |
| 148 | bile acid and bile salt transport (GO:0015721) | 2.66114144 |
| 149 | transcytosis (GO:0045056) | 2.65725688 |
| 150 | heterotypic cell-cell adhesion (GO:0034113) | 2.64956374 |
| 151 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.64723485 |
| 152 | protein O-linked glycosylation (GO:0006493) | 2.63383193 |
| 153 | neurotransmitter biosynthetic process (GO:0042136) | 2.60251033 |
| 154 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.59192473 |
| 155 | cardiac conduction (GO:0061337) | 2.59144222 |
| 156 | L-fucose catabolic process (GO:0042355) | 2.58869947 |
| 157 | fucose catabolic process (GO:0019317) | 2.58869947 |
| 158 | L-fucose metabolic process (GO:0042354) | 2.58869947 |
| 159 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.55817066 |
| 160 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.55817066 |
| 161 | reverse cholesterol transport (GO:0043691) | 2.53290672 |
| 162 | lipoprotein transport (GO:0042953) | 2.52941340 |
| 163 | thrombin receptor signaling pathway (GO:0070493) | 2.51829214 |
| 164 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.50549661 |
| 165 | flavonoid metabolic process (GO:0009812) | 2.50162213 |
| 166 | positive regulation of pseudopodium assembly (GO:0031274) | 2.49828191 |
| 167 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.47681240 |
| 168 | regulation of chemokine secretion (GO:0090196) | 2.46822151 |
| 169 | hydrogen peroxide metabolic process (GO:0042743) | 2.46260925 |
| 170 | adenosine receptor signaling pathway (GO:0001973) | 2.46048800 |
| 171 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.45912905 |
| 172 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.45815654 |
| 173 | negative regulation of sodium ion transport (GO:0010766) | 2.45770425 |
| 174 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.45737995 |
| 175 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.44710195 |
| 176 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.42848946 |
| 177 | thyroid hormone generation (GO:0006590) | 2.41688853 |
| 178 | N-acetylneuraminate metabolic process (GO:0006054) | 2.40040627 |
| 179 | prepulse inhibition (GO:0060134) | 2.38703457 |
| 180 | sialylation (GO:0097503) | 2.36843956 |
| 181 | regulation of actin nucleation (GO:0051125) | 2.36275063 |
| 182 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.36126121 |
| 183 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.34370097 |
| 184 | positive regulation of actin filament depolymerization (GO:0030836) | 2.31641205 |
| 185 | response to hydroperoxide (GO:0033194) | 2.31497187 |
| 186 | antimicrobial humoral response (GO:0019730) | 2.30920937 |
| 187 | antibacterial humoral response (GO:0019731) | 2.29001981 |
| 188 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.28519367 |
| 189 | response to bacterium (GO:0009617) | 2.27696854 |
| 190 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.27045762 |
| 191 | protein autoprocessing (GO:0016540) | 2.26805489 |
| 192 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.25602628 |
| 193 | potassium ion homeostasis (GO:0055075) | 2.25364409 |
| 194 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.24143289 |
| 195 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.24143289 |
| 196 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.23902006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.83706159 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.81830752 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.85125740 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.77045373 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.99334212 |
| 6 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.33142283 |
| 7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.24293144 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.03457688 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.01066978 |
| 10 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.91712101 |
| 11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.89177814 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.85865327 |
| 13 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.72418191 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.61243197 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.60711028 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44262905 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.37225509 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.28421274 |
| 19 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.27847632 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.19224407 |
| 21 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.17623901 |
| 22 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.14955162 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.14660895 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.13495935 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.12927976 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.07827802 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01116081 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.00964533 |
| 29 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.98440383 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.82586431 |
| 31 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.77357017 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76315996 |
| 33 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68386597 |
| 34 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.66119490 |
| 35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65361342 |
| 36 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.65110875 |
| 37 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.60992795 |
| 38 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.60992795 |
| 39 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.60992795 |
| 40 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.58761518 |
| 41 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58373607 |
| 42 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56560735 |
| 43 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.54098423 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54074632 |
| 45 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.53958899 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52346386 |
| 47 | MYB_26560356_Chip-Seq_TH2_Human | 1.51539802 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.50884841 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47951005 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.45476926 |
| 51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.44359857 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44079943 |
| 53 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.40744977 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40653065 |
| 55 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.39333488 |
| 56 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.38992479 |
| 57 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35932439 |
| 58 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.35268865 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34189139 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33934587 |
| 61 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.33325703 |
| 62 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.33075059 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31167401 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29863311 |
| 65 | MAF_26560356_Chip-Seq_TH1_Human | 1.29617698 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28506252 |
| 67 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.26648605 |
| 68 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25034051 |
| 69 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.24263255 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22831355 |
| 71 | MYB_26560356_Chip-Seq_TH1_Human | 1.20765338 |
| 72 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.19290804 |
| 73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19277878 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17161662 |
| 75 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.15630289 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14955808 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13936351 |
| 78 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.13893107 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13867852 |
| 80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13388219 |
| 81 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.13048805 |
| 82 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09736864 |
| 83 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09712975 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09574886 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09358246 |
| 86 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.08905941 |
| 87 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.08686109 |
| 88 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.08485125 |
| 89 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07632269 |
| 90 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.06740257 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05434977 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05317733 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.05024386 |
| 94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04064327 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03911606 |
| 96 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03771203 |
| 97 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03589270 |
| 98 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03181825 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03124731 |
| 100 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02281193 |
| 101 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01824680 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01111794 |
| 103 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00682784 |
| 104 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00309077 |
| 105 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.99666015 |
| 106 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97656155 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97506342 |
| 108 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.97503411 |
| 109 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97016196 |
| 110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96406076 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95912068 |
| 112 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94746454 |
| 113 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94613607 |
| 114 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94547389 |
| 115 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.94353139 |
| 116 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.94353139 |
| 117 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.93202400 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92078744 |
| 119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92045331 |
| 120 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91940129 |
| 121 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.91910972 |
| 122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91336529 |
| 123 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90043649 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89783225 |
| 125 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89728754 |
| 126 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89437290 |
| 127 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89280568 |
| 128 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.88866493 |
| 129 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.87732531 |
| 130 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86966675 |
| 131 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.86121279 |
| 132 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86014710 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85882917 |
| 134 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85310891 |
| 135 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.85093333 |
| 136 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.85064854 |
| 137 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.84312935 |
| 138 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84230913 |
| 139 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84128446 |
| 140 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83243524 |
| 141 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.82929020 |
| 142 | ATF3_27146783_Chip-Seq_COLON_Human | 0.82598567 |
| 143 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81653451 |
| 144 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81600496 |
| 145 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81600496 |
| 146 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.81307040 |
| 147 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81077322 |
| 148 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.80785228 |
| 149 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.80706502 |
| 150 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80205834 |
| 151 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.80129439 |
| 152 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79617338 |
| 153 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79219037 |
| 154 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78532142 |
| 155 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.78153989 |
| 156 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77315887 |
| 157 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77056574 |
| 158 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76776103 |
| 159 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.75121893 |
| 160 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.70694494 |
| 161 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.70649182 |
| 162 | UTX_26944678_Chip-Seq_JUKART_Human | 0.69766915 |
| 163 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.69510361 |
| 164 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.69042182 |
| 165 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68277340 |
| 166 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.66141848 |
| 167 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.64949857 |
| 168 | MAF_26560356_Chip-Seq_TH2_Human | 0.62968456 |
| 169 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.61478404 |
| 170 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.60887183 |
| 171 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.59415079 |
| 172 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.58532466 |
| 173 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.57056246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 5.62210790 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 5.29531357 |
| 3 | MP0002254_reproductive_system_inflammat | 4.27509583 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 3.82980795 |
| 5 | MP0006082_CNS_inflammation | 3.81168097 |
| 6 | MP0000685_abnormal_immune_system | 3.48075733 |
| 7 | MP0005360_urolithiasis | 3.28988482 |
| 8 | MP0005387_immune_system_phenotype | 3.15016143 |
| 9 | MP0001790_abnormal_immune_system | 3.15016143 |
| 10 | MP0005671_abnormal_response_to | 3.13155051 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.98620613 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.95076856 |
| 13 | MP0004510_myositis | 2.87765440 |
| 14 | MP0005451_abnormal_body_composition | 2.79246438 |
| 15 | MP0003866_abnormal_defecation | 2.78156140 |
| 16 | MP0003436_decreased_susceptibility_to | 2.76676409 |
| 17 | MP0001800_abnormal_humoral_immune | 2.73173393 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.64803133 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.54513548 |
| 20 | * MP0002452_abnormal_antigen_presenting | 2.49147679 |
| 21 | * MP0002723_abnormal_immune_serum | 2.42495457 |
| 22 | MP0002419_abnormal_innate_immunity | 2.40559541 |
| 23 | MP0002876_abnormal_thyroid_physiology | 2.18019101 |
| 24 | MP0001873_stomach_inflammation | 2.13247087 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.07930455 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 2.04769359 |
| 27 | MP0003303_peritoneal_inflammation | 2.00891592 |
| 28 | MP0004043_abnormal_pH_regulation | 1.95629983 |
| 29 | * MP0001819_abnormal_immune_cell | 1.94635308 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.90369574 |
| 31 | MP0001881_abnormal_mammary_gland | 1.84895249 |
| 32 | MP0003878_abnormal_ear_physiology | 1.81465615 |
| 33 | MP0005377_hearing/vestibular/ear_phenot | 1.81465615 |
| 34 | MP0003075_altered_response_to | 1.79629481 |
| 35 | MP0008469_abnormal_protein_level | 1.79269354 |
| 36 | MP0001663_abnormal_digestive_system | 1.78137167 |
| 37 | MP0005166_decreased_susceptibility_to | 1.76580894 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.74578998 |
| 39 | MP0003448_altered_tumor_morphology | 1.71128765 |
| 40 | MP0010329_abnormal_lipoprotein_level | 1.68064072 |
| 41 | MP0000343_altered_response_to | 1.67374844 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.66346517 |
| 43 | MP0002405_respiratory_system_inflammati | 1.64644380 |
| 44 | MP0000537_abnormal_urethra_morphology | 1.60716755 |
| 45 | MP0005248_abnormal_Harderian_gland | 1.60513391 |
| 46 | MP0000462_abnormal_digestive_system | 1.55871733 |
| 47 | MP0001501_abnormal_sleep_pattern | 1.53391433 |
| 48 | MP0005310_abnormal_salivary_gland | 1.50131532 |
| 49 | MP0003195_calcinosis | 1.48899487 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.48852334 |
| 51 | MP0003252_abnormal_bile_duct | 1.48130780 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.48120641 |
| 53 | MP0004947_skin_inflammation | 1.47454789 |
| 54 | MP0005381_digestive/alimentary_phenotyp | 1.45615517 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.43295664 |
| 56 | MP0000716_abnormal_immune_system | 1.42984742 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.41438093 |
| 58 | MP0009785_altered_susceptibility_to | 1.41381659 |
| 59 | MP0001765_abnormal_ion_homeostasis | 1.40562229 |
| 60 | MP0008872_abnormal_physiological_respon | 1.40431025 |
| 61 | MP0010678_abnormal_skin_adnexa | 1.39737097 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.36076737 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.33775557 |
| 64 | MP0008004_abnormal_stomach_pH | 1.32995786 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.31961476 |
| 66 | MP0002796_impaired_skin_barrier | 1.31829092 |
| 67 | MP0001346_abnormal_lacrimal_gland | 1.30975495 |
| 68 | MP0000477_abnormal_intestine_morphology | 1.30948884 |
| 69 | MP0004270_analgesia | 1.26431335 |
| 70 | MP0003329_amyloid_beta_deposits | 1.23041280 |
| 71 | MP0000604_amyloidosis | 1.22957896 |
| 72 | MP0009278_abnormal_bone_marrow | 1.21240433 |
| 73 | MP0001664_abnormal_digestion | 1.20644967 |
| 74 | MP0001348_abnormal_lacrimal_gland | 1.20223644 |
| 75 | MP0000490_abnormal_crypts_of | 1.19588598 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 1.19250834 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.19250834 |
| 78 | MP0000013_abnormal_adipose_tissue | 1.18897277 |
| 79 | MP0004858_abnormal_nervous_system | 1.18730299 |
| 80 | MP0004883_abnormal_blood_vessel | 1.18072089 |
| 81 | MP0002398_abnormal_bone_marrow | 1.17828077 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.17466201 |
| 83 | MP0005365_abnormal_bile_salt | 1.16708383 |
| 84 | MP0009763_increased_sensitivity_to | 1.14979673 |
| 85 | MP0003183_abnormal_peptide_metabolism | 1.14726010 |
| 86 | MP0002163_abnormal_gland_morphology | 1.14687722 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 1.14353893 |
| 88 | MP0005164_abnormal_response_to | 1.13890268 |
| 89 | MP0002006_tumorigenesis | 1.11588342 |
| 90 | MP0003045_fibrosis | 1.11364623 |
| 91 | MP0003724_increased_susceptibility_to | 1.10344569 |
| 92 | MP0000858_altered_metastatic_potential | 1.08840754 |
| 93 | MP0006054_spinal_hemorrhage | 1.08221460 |
| 94 | MP0005623_abnormal_meninges_morphology | 1.07608447 |
| 95 | MP0002429_abnormal_blood_cell | 1.07176742 |
| 96 | MP0001440_abnormal_grooming_behavior | 1.06226656 |
| 97 | MP0002166_altered_tumor_susceptibility | 1.03997785 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03070680 |
| 99 | MP0001529_abnormal_vocalization | 1.02749791 |
| 100 | MP0003646_muscle_fatigue | 1.01077640 |
| 101 | MP0009643_abnormal_urine_homeostasis | 0.99626750 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.98752626 |
| 103 | MP0003941_abnormal_skin_development | 0.98273535 |
| 104 | MP0003806_abnormal_nucleotide_metabolis | 0.98000946 |
| 105 | MP0005636_abnormal_mineral_homeostasis | 0.97434115 |
| 106 | MP0009840_abnormal_foam_cell | 0.96940702 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.96185658 |
| 108 | MP0001533_abnormal_skeleton_physiology | 0.95233032 |
| 109 | MP0004859_abnormal_synaptic_plasticity | 0.94190367 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.93858443 |
| 111 | MP0001853_heart_inflammation | 0.91616508 |
| 112 | MP0008260_abnormal_autophagy | 0.90129179 |
| 113 | MP0002722_abnormal_immune_system | 0.89561667 |
| 114 | MP0004019_abnormal_vitamin_homeostasis | 0.89091011 |
| 115 | MP0010352_gastrointestinal_tract_polyps | 0.89000547 |
| 116 | MP0001849_ear_inflammation | 0.87043601 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.86797718 |
| 118 | MP0005165_increased_susceptibility_to | 0.85855369 |
| 119 | MP0000689_abnormal_spleen_morphology | 0.85636299 |
| 120 | MP0003091_abnormal_cell_migration | 0.85555526 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.84014325 |
| 122 | MP0000627_abnormal_mammary_gland | 0.83843851 |
| 123 | MP0005025_abnormal_response_to | 0.83212501 |
| 124 | MP0002118_abnormal_lipid_homeostasis | 0.82260832 |
| 125 | MP0002733_abnormal_thermal_nociception | 0.81827634 |
| 126 | MP0002098_abnormal_vibrissa_morphology | 0.80803973 |
| 127 | MP0004782_abnormal_surfactant_physiolog | 0.80088950 |
| 128 | MP0002148_abnormal_hypersensitivity_rea | 0.77550567 |
| 129 | MP0009764_decreased_sensitivity_to | 0.77157364 |
| 130 | MP0000538_abnormal_urinary_bladder | 0.76894827 |
| 131 | MP0001845_abnormal_inflammatory_respons | 0.76726938 |
| 132 | MP0003763_abnormal_thymus_physiology | 0.75948145 |
| 133 | MP0002896_abnormal_bone_mineralization | 0.75306449 |
| 134 | MP0001835_abnormal_antigen_presentation | 0.75066209 |
| 135 | MP0003453_abnormal_keratinocyte_physiol | 0.74467558 |
| 136 | MP0005390_skeleton_phenotype | 0.73068566 |
| 137 | MP0003879_abnormal_hair_cell | 0.72623853 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.72084486 |
| 139 | MP0008873_increased_physiological_sensi | 0.71030286 |
| 140 | MP0003705_abnormal_hypodermis_morpholog | 0.70526465 |
| 141 | MP0009745_abnormal_behavioral_response | 0.69824516 |
| 142 | MP0004130_abnormal_muscle_cell | 0.69692139 |
| 143 | MP0002136_abnormal_kidney_physiology | 0.69349383 |
| 144 | MP0003656_abnormal_erythrocyte_physiolo | 0.68691225 |
| 145 | MP0005332_abnormal_amino_acid | 0.67771005 |
| 146 | MP0000427_abnormal_hair_cycle | 0.67265215 |
| 147 | MP0005379_endocrine/exocrine_gland_phen | 0.66353062 |
| 148 | MP0002693_abnormal_pancreas_physiology | 0.65253630 |
| 149 | MP0003690_abnormal_glial_cell | 0.64577751 |
| 150 | MP0000609_abnormal_liver_physiology | 0.64130625 |
| 151 | MP0008874_decreased_physiological_sensi | 0.62778660 |
| 152 | MP0004808_abnormal_hematopoietic_stem | 0.59420720 |
| 153 | MP0002877_abnormal_melanocyte_morpholog | 0.59398521 |
| 154 | MP0000920_abnormal_myelination | 0.57305291 |
| 155 | MP0010307_abnormal_tumor_latency | 0.56766607 |
| 156 | MP0003795_abnormal_bone_structure | 0.51706701 |
| 157 | MP0005647_abnormal_sex_gland | 0.51041381 |
| 158 | MP0003221_abnormal_cardiomyocyte_apopto | 0.50011016 |
| 159 | MP0000249_abnormal_blood_vessel | 0.49188241 |
| 160 | MP0000371_diluted_coat_color | 0.47717333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 6.66891671 |
| 2 | Optic neuritis (HP:0100653) | 6.35972848 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 6.35972848 |
| 4 | Orchitis (HP:0100796) | 6.05721105 |
| 5 | Pustule (HP:0200039) | 5.77969498 |
| 6 | Gastrointestinal infarctions (HP:0005244) | 5.77513428 |
| 7 | Myositis (HP:0100614) | 5.15624369 |
| 8 | Malnutrition (HP:0004395) | 5.09601383 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.96825950 |
| 10 | Oligomenorrhea (HP:0000876) | 4.94041701 |
| 11 | Prostate neoplasm (HP:0100787) | 4.80362302 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.57335038 |
| 13 | Keratoconjunctivitis sicca (HP:0001097) | 4.42441747 |
| 14 | Hemoptysis (HP:0002105) | 4.37461805 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 4.32379075 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.32379075 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.32379075 |
| 18 | Increased IgM level (HP:0003496) | 4.32267942 |
| 19 | Recurrent abscess formation (HP:0002722) | 4.27464525 |
| 20 | Abnormality of small intestinal villus morphology (HP:0011472) | 4.18614184 |
| 21 | Villous atrophy (HP:0011473) | 4.18614184 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 4.11195001 |
| 23 | Keratoconjunctivitis (HP:0001096) | 4.05821477 |
| 24 | Vasculitis (HP:0002633) | 3.97574904 |
| 25 | Gangrene (HP:0100758) | 3.94052354 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.87396776 |
| 27 | Hematochezia (HP:0002573) | 3.79209940 |
| 28 | Onycholysis (HP:0001806) | 3.67728024 |
| 29 | Pulmonary infiltrates (HP:0002113) | 3.60332890 |
| 30 | Stomatitis (HP:0010280) | 3.56038584 |
| 31 | Milia (HP:0001056) | 3.45306893 |
| 32 | Ileus (HP:0002595) | 3.43095413 |
| 33 | Polygenic inheritance (HP:0010982) | 3.37300310 |
| 34 | Palpitations (HP:0001962) | 3.36147107 |
| 35 | Amaurosis fugax (HP:0100576) | 3.31414035 |
| 36 | Recurrent viral infections (HP:0004429) | 3.31099137 |
| 37 | Anorexia (HP:0002039) | 3.25990944 |
| 38 | Goiter (HP:0000853) | 3.20523085 |
| 39 | Loss of speech (HP:0002371) | 3.19541450 |
| 40 | Arterial thrombosis (HP:0004420) | 3.14946905 |
| 41 | Recurrent fungal infections (HP:0002841) | 3.13797052 |
| 42 | Micronodular cirrhosis (HP:0001413) | 3.12940583 |
| 43 | Chronic otitis media (HP:0000389) | 3.12452237 |
| 44 | Recurrent skin infections (HP:0001581) | 3.07873594 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 3.06397628 |
| 46 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.99907518 |
| 47 | Cheilitis (HP:0100825) | 2.99896776 |
| 48 | Chronic diarrhea (HP:0002028) | 2.97051997 |
| 49 | Abnormality of T cell number (HP:0011839) | 2.94917326 |
| 50 | Chest pain (HP:0100749) | 2.92112302 |
| 51 | Amyloidosis (HP:0011034) | 2.91874808 |
| 52 | T lymphocytopenia (HP:0005403) | 2.90765726 |
| 53 | Premature loss of primary teeth (HP:0006323) | 2.90092665 |
| 54 | Abdominal distention (HP:0003270) | 2.88752033 |
| 55 | Flat acetabular roof (HP:0003180) | 2.85380577 |
| 56 | Alopecia of scalp (HP:0002293) | 2.85211216 |
| 57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.78897659 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78166549 |
| 59 | Disinhibition (HP:0000734) | 2.77191042 |
| 60 | Encephalitis (HP:0002383) | 2.76283588 |
| 61 | Abnormality of proline metabolism (HP:0010907) | 2.75530104 |
| 62 | Hydroxyprolinuria (HP:0003080) | 2.75530104 |
| 63 | Hyperactive renin-angiotensin system (HP:0000841) | 2.74377803 |
| 64 | Hypertensive crisis (HP:0100735) | 2.74127004 |
| 65 | Vascular calcification (HP:0004934) | 2.72897193 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.70856422 |
| 67 | Myokymia (HP:0002411) | 2.68334040 |
| 68 | Pili torti (HP:0003777) | 2.65945578 |
| 69 | Abnormality of the pleura (HP:0002103) | 2.64822186 |
| 70 | Leukocytosis (HP:0001974) | 2.64652096 |
| 71 | Meningitis (HP:0001287) | 2.62437348 |
| 72 | Vacuolated lymphocytes (HP:0001922) | 2.61357446 |
| 73 | Xanthomatosis (HP:0000991) | 2.61353003 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.59271899 |
| 75 | Obstructive lung disease (HP:0006536) | 2.59271899 |
| 76 | Abnormality of the nasal mucosa (HP:0000433) | 2.59246338 |
| 77 | Nasal polyposis (HP:0100582) | 2.58571078 |
| 78 | Fragile nails (HP:0001808) | 2.58190584 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.57760152 |
| 80 | Dehydration (HP:0001944) | 2.57304514 |
| 81 | IgA deficiency (HP:0002720) | 2.57256018 |
| 82 | Recurrent bronchitis (HP:0002837) | 2.57055176 |
| 83 | Abnormality of the pericardium (HP:0001697) | 2.54243508 |
| 84 | Abnormality of B cell number (HP:0010975) | 2.51917193 |
| 85 | Focal segmental glomerulosclerosis (HP:0000097) | 2.51902257 |
| 86 | Joint swelling (HP:0001386) | 2.50078592 |
| 87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.48291864 |
| 88 | Abnormality of the endocardium (HP:0004306) | 2.46726959 |
| 89 | Recurrent cutaneous fungal infections (HP:0011370) | 2.46343236 |
| 90 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.46343236 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.46252607 |
| 92 | Widely patent fontanelles and sutures (HP:0004492) | 2.45065156 |
| 93 | Glomerulonephritis (HP:0000099) | 2.44600474 |
| 94 | Prolonged QT interval (HP:0001657) | 2.43646080 |
| 95 | Esophageal varix (HP:0002040) | 2.41978712 |
| 96 | Peritonitis (HP:0002586) | 2.40573717 |
| 97 | Progressive neurologic deterioration (HP:0002344) | 2.39339072 |
| 98 | Polyneuropathy (HP:0001271) | 2.35967479 |
| 99 | Thin bony cortex (HP:0002753) | 2.30478644 |
| 100 | Pulmonary embolism (HP:0002204) | 2.30155314 |
| 101 | Increased IgE level (HP:0003212) | 2.29484122 |
| 102 | Atrophic scars (HP:0001075) | 2.29132083 |
| 103 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28061461 |
| 104 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28061461 |
| 105 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28061461 |
| 106 | Glomerulopathy (HP:0100820) | 2.27806184 |
| 107 | Increased serum ferritin (HP:0003281) | 2.27581487 |
| 108 | Ketoacidosis (HP:0001993) | 2.27269388 |
| 109 | Broad metatarsal (HP:0001783) | 2.26665720 |
| 110 | Vertigo (HP:0002321) | 2.26205463 |
| 111 | Hypobetalipoproteinemia (HP:0003563) | 2.25010783 |
| 112 | Hypolipoproteinemia (HP:0010981) | 2.24893238 |
| 113 | Mucopolysacchariduria (HP:0008155) | 2.24490162 |
| 114 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24490162 |
| 115 | B lymphocytopenia (HP:0010976) | 2.23962416 |
| 116 | Hypercholesterolemia (HP:0003124) | 2.23643850 |
| 117 | Plantar hyperkeratosis (HP:0007556) | 2.21230347 |
| 118 | Abnormality of purine metabolism (HP:0004352) | 2.21074591 |
| 119 | Ankyloglossia (HP:0010296) | 2.20438931 |
| 120 | Urticaria (HP:0001025) | 2.20021152 |
| 121 | Eosinophilia (HP:0001880) | 2.19434711 |
| 122 | Woolly hair (HP:0002224) | 2.18226621 |
| 123 | Gingivitis (HP:0000230) | 2.18204715 |
| 124 | Intrahepatic cholestasis (HP:0001406) | 2.17605558 |
| 125 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.15715450 |
| 126 | Acanthocytosis (HP:0001927) | 2.15655254 |
| 127 | Abnormal tarsal ossification (HP:0008369) | 2.15234045 |
| 128 | Myocardial infarction (HP:0001658) | 2.15008341 |
| 129 | Parakeratosis (HP:0001036) | 2.12730657 |
| 130 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.12444878 |
| 131 | Facial shape deformation (HP:0011334) | 2.11878134 |
| 132 | Potter facies (HP:0002009) | 2.11878134 |
| 133 | Abnormality of the gastric mucosa (HP:0004295) | 2.10349973 |
| 134 | Hyperphosphatemia (HP:0002905) | 2.09904636 |
| 135 | Basal ganglia calcification (HP:0002135) | 2.09605063 |
| 136 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.08778077 |
| 137 | Ventricular tachycardia (HP:0004756) | 2.08629691 |
| 138 | Hypoalphalipoproteinemia (HP:0003233) | 2.07403303 |
| 139 | Keratitis (HP:0000491) | 2.07264508 |
| 140 | Autoimmune hemolytic anemia (HP:0001890) | 2.06507510 |
| 141 | Toxemia of pregnancy (HP:0100603) | 2.04627279 |
| 142 | Arthralgia (HP:0002829) | 2.04421574 |
| 143 | Cerebral ischemia (HP:0002637) | 2.03600930 |
| 144 | Hypoplasia of dental enamel (HP:0006297) | 2.02219927 |
| 145 | Episodic fever (HP:0001954) | 2.02059633 |
| 146 | Acne (HP:0001061) | 1.97544503 |
| 147 | Abnormality of the prostate (HP:0008775) | 1.97452232 |
| 148 | Enlarged epiphyses (HP:0010580) | 1.97434341 |
| 149 | Memory impairment (HP:0002354) | 1.95373852 |
| 150 | Thrombophlebitis (HP:0004418) | 1.95118480 |
| 151 | Biliary tract neoplasm (HP:0100574) | 1.93538407 |
| 152 | Eczematoid dermatitis (HP:0000976) | 1.90151542 |
| 153 | Abnormality of the 1st metacarpal (HP:0010009) | 1.88758726 |
| 154 | Dysostosis multiplex (HP:0000943) | 1.87849086 |
| 155 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.86838923 |
| 156 | Bronchomalacia (HP:0002780) | 1.84320038 |
| 157 | Fat malabsorption (HP:0002630) | 1.84310667 |
| 158 | Sensorimotor neuropathy (HP:0007141) | 1.84258027 |
| 159 | Inflammation of the large intestine (HP:0002037) | 1.83602118 |
| 160 | Hemorrhage of the eye (HP:0011885) | 1.83379291 |
| 161 | Acanthosis nigricans (HP:0000956) | 1.83252458 |
| 162 | Abnormality of chloride homeostasis (HP:0011422) | 1.79355363 |
| 163 | Complement deficiency (HP:0004431) | 1.79138923 |
| 164 | Colitis (HP:0002583) | 1.78162011 |
| 165 | Glomerulosclerosis (HP:0000096) | 1.77036766 |
| 166 | Abnormal glucose tolerance (HP:0001952) | 1.75611581 |
| 167 | Multifactorial inheritance (HP:0001426) | 1.75556445 |
| 168 | Late onset (HP:0003584) | 1.73608412 |
| 169 | Stomach cancer (HP:0012126) | 1.72454643 |
| 170 | Ventricular fibrillation (HP:0001663) | 1.70839385 |
| 171 | Conjugated hyperbilirubinemia (HP:0002908) | 1.70800566 |
| 172 | Ventricular arrhythmia (HP:0004308) | 1.69491755 |
| 173 | Interstitial pulmonary disease (HP:0006530) | 1.66496189 |
| 174 | Progressive hearing impairment (HP:0001730) | 1.66207466 |
| 175 | Gastrointestinal inflammation (HP:0004386) | 1.65175955 |
| 176 | Neoplasm of the small intestine (HP:0100833) | 1.65103917 |
| 177 | Gastrointestinal stroma tumor (HP:0100723) | 1.64972250 |
| 178 | Hoarse voice (HP:0001609) | 1.64786936 |
| 179 | Proximal tubulopathy (HP:0000114) | 1.64274211 |
| 180 | Neoplasm of the rectum (HP:0100743) | 1.63941426 |
| 181 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.63605958 |
| 182 | Hypertriglyceridemia (HP:0002155) | 1.63204304 |
| 183 | Rectal prolapse (HP:0002035) | 1.62678324 |
| 184 | Progressive sensorineural hearing impairment (HP:0000408) | 1.61435041 |
| 185 | Distal lower limb amyotrophy (HP:0008944) | 1.60435557 |
| 186 | Hypoglycemic coma (HP:0001325) | 1.59987014 |
| 187 | Syncope (HP:0001279) | 1.59247207 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 7.85362807 |
| 2 | PIK3CA | 5.31309964 |
| 3 | IRAK3 | 4.63599505 |
| 4 | MAP3K2 | 3.85533343 |
| 5 | EPHA2 | 3.82979937 |
| 6 | MST4 | 3.80391763 |
| 7 | JAK3 | 3.17066918 |
| 8 | KSR2 | 2.95354797 |
| 9 | MET | 2.93655979 |
| 10 | FRK | 2.72043961 |
| 11 | MAP2K2 | 2.70166510 |
| 12 | ADRBK2 | 2.48578841 |
| 13 | EPHA4 | 2.20831021 |
| 14 | IRAK4 | 2.14838884 |
| 15 | NME1 | 2.13916573 |
| 16 | PRPF4B | 2.12844583 |
| 17 | LMTK2 | 2.10271278 |
| 18 | IKBKB | 2.03656705 |
| 19 | TAOK2 | 1.91179354 |
| 20 | MAP2K1 | 1.80820413 |
| 21 | TXK | 1.80541716 |
| 22 | CDC42BPA | 1.75926492 |
| 23 | MAP4K1 | 1.72527553 |
| 24 | NME2 | 1.63755480 |
| 25 | RIPK4 | 1.58931489 |
| 26 | EPHB1 | 1.58054993 |
| 27 | PRKG2 | 1.48705554 |
| 28 | TESK1 | 1.47660153 |
| 29 | PIM2 | 1.46471046 |
| 30 | ERN1 | 1.35810156 |
| 31 | BLK | 1.34214229 |
| 32 | CHUK | 1.30905614 |
| 33 | RIPK1 | 1.28321495 |
| 34 | PTK6 | 1.25730390 |
| 35 | DMPK | 1.18201403 |
| 36 | STK39 | 1.16748196 |
| 37 | MAP3K1 | 1.16025066 |
| 38 | FER | 1.12346271 |
| 39 | ZAP70 | 1.10497023 |
| 40 | MOS | 1.08826359 |
| 41 | FGFR4 | 1.06761932 |
| 42 | TYRO3 | 1.03572624 |
| 43 | LYN | 1.02324540 |
| 44 | RET | 1.00871364 |
| 45 | CAMK2D | 0.97717342 |
| 46 | TAOK1 | 0.97297413 |
| 47 | MAPKAPK5 | 0.89186932 |
| 48 | MAP3K11 | 0.88545143 |
| 49 | FGFR2 | 0.87962129 |
| 50 | GRK6 | 0.87672258 |
| 51 | MAP3K12 | 0.84823565 |
| 52 | SYK | 0.84001142 |
| 53 | JAK2 | 0.82887794 |
| 54 | CLK1 | 0.82026627 |
| 55 | BMX | 0.81038789 |
| 56 | FGFR3 | 0.80003367 |
| 57 | PTK2 | 0.79793493 |
| 58 | EPHA3 | 0.79188113 |
| 59 | AKT3 | 0.76193773 |
| 60 | NLK | 0.73803313 |
| 61 | OXSR1 | 0.73167788 |
| 62 | LCK | 0.73005813 |
| 63 | IRAK2 | 0.72996191 |
| 64 | MAP3K5 | 0.71287540 |
| 65 | ACVR1B | 0.71086546 |
| 66 | SIK3 | 0.69315694 |
| 67 | DYRK3 | 0.69288362 |
| 68 | LRRK2 | 0.68052827 |
| 69 | HIPK2 | 0.62209834 |
| 70 | TBK1 | 0.60802960 |
| 71 | MAP3K9 | 0.59091014 |
| 72 | PKN1 | 0.58966862 |
| 73 | IKBKE | 0.58481726 |
| 74 | CDK6 | 0.56671439 |
| 75 | STK10 | 0.56286008 |
| 76 | MAP3K13 | 0.56154888 |
| 77 | BTK | 0.54985665 |
| 78 | PIM1 | 0.54431103 |
| 79 | HCK | 0.53604732 |
| 80 | MARK3 | 0.52969208 |
| 81 | TAOK3 | 0.52747706 |
| 82 | NTRK3 | 0.52546341 |
| 83 | SIK1 | 0.52186234 |
| 84 | PDGFRA | 0.51373475 |
| 85 | NEK9 | 0.51082943 |
| 86 | CDK5 | 0.49834457 |
| 87 | TYK2 | 0.49100681 |
| 88 | MATK | 0.48521437 |
| 89 | EPHB2 | 0.48475246 |
| 90 | JAK1 | 0.47099661 |
| 91 | MAP3K3 | 0.45556768 |
| 92 | EGFR | 0.45096123 |
| 93 | CAMK2B | 0.44432772 |
| 94 | SRC | 0.40810932 |
| 95 | CDK19 | 0.40213873 |
| 96 | MAP3K7 | 0.39880868 |
| 97 | KIT | 0.39646819 |
| 98 | PDK1 | 0.39058700 |
| 99 | PTK2B | 0.38200639 |
| 100 | FYN | 0.38093458 |
| 101 | MAP2K6 | 0.38003973 |
| 102 | DDR2 | 0.37459552 |
| 103 | MYLK | 0.36998525 |
| 104 | PAK4 | 0.36956856 |
| 105 | CAMK1D | 0.36482010 |
| 106 | GRK7 | 0.36249427 |
| 107 | CDK9 | 0.35809952 |
| 108 | PKN2 | 0.34465807 |
| 109 | TRIB3 | 0.34040435 |
| 110 | CAMK2G | 0.33814029 |
| 111 | CSF1R | 0.33700958 |
| 112 | PRKAA2 | 0.33155895 |
| 113 | DAPK2 | 0.32052923 |
| 114 | DAPK3 | 0.31871965 |
| 115 | PRKCQ | 0.31502310 |
| 116 | LATS2 | 0.31498787 |
| 117 | ABL1 | 0.30675969 |
| 118 | TNK2 | 0.29862955 |
| 119 | ALK | 0.29773046 |
| 120 | CSK | 0.29185024 |
| 121 | CDK4 | 0.29026699 |
| 122 | ARAF | 0.28822612 |
| 123 | PRKCH | 0.28737281 |
| 124 | PDPK1 | 0.28190278 |
| 125 | ABL2 | 0.27908020 |
| 126 | CAMKK1 | 0.27720614 |
| 127 | RPS6KA5 | 0.27286539 |
| 128 | PDGFRB | 0.27264595 |
| 129 | TESK2 | 0.27240362 |
| 130 | PRKCI | 0.26712936 |
| 131 | MAP3K8 | 0.26172726 |
| 132 | INSR | 0.25788093 |
| 133 | PRKCA | 0.24798047 |
| 134 | PRKACG | 0.24656060 |
| 135 | MAP2K3 | 0.23939578 |
| 136 | MAP3K14 | 0.23346112 |
| 137 | TGFBR2 | 0.23112831 |
| 138 | IGF1R | 0.22917700 |
| 139 | STK24 | 0.22526978 |
| 140 | BMPR2 | 0.21415128 |
| 141 | MAPK11 | 0.21067041 |
| 142 | ERBB2 | 0.20778997 |
| 143 | PRKCE | 0.20607228 |
| 144 | ERBB3 | 0.20040783 |
| 145 | FGR | 0.20029129 |
| 146 | IRAK1 | 0.19836422 |
| 147 | FES | 0.19607207 |
| 148 | YES1 | 0.19371235 |
| 149 | PRKCD | 0.18113150 |
| 150 | MINK1 | 0.17853085 |
| 151 | MAPK7 | 0.17729456 |
| 152 | MAPK4 | 0.14288898 |
| 153 | EIF2AK2 | 0.12671396 |
| 154 | MAPK3 | 0.12184862 |
| 155 | CDK14 | 0.11929162 |
| 156 | MAPKAPK2 | 0.11638474 |
| 157 | DAPK1 | 0.11441374 |
| 158 | CDK15 | 0.10313060 |
| 159 | DYRK1B | 0.08345058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.24770884 |
| 2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.57145746 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.29341304 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.28828718 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.24596648 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.23551086 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.19893016 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.16507738 |
| 9 | Mineral absorption_Homo sapiens_hsa04978 | 3.01758786 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.98105755 |
| 11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.93926318 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.70934821 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.68190906 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.63523719 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.55843194 |
| 16 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 2.49021452 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.42719934 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.31429045 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.27444958 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.24725335 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 2.20308266 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.17298207 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 2.13188740 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.07573543 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.96720271 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.94281375 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.92222098 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89130193 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.88162148 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.82713667 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.81638214 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.80251051 |
| 33 | Legionellosis_Homo sapiens_hsa05134 | 1.79891963 |
| 34 | Measles_Homo sapiens_hsa05162 | 1.78587785 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.75056423 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.67246059 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.64820245 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58197708 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.56891326 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.45481001 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.44491157 |
| 42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43679499 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42192110 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.34598304 |
| 45 | Lysosome_Homo sapiens_hsa04142 | 1.34319080 |
| 46 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.31165923 |
| 47 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.28600502 |
| 48 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.28041293 |
| 49 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.26366347 |
| 50 | Histidine metabolism_Homo sapiens_hsa00340 | 1.26123828 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22221096 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.20545949 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.20374563 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.18175930 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13469426 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13175435 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 1.09620907 |
| 58 | Cocaine addiction_Homo sapiens_hsa05030 | 1.07950055 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 1.05082577 |
| 60 | Thyroid cancer_Homo sapiens_hsa05216 | 1.04894700 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 1.04651249 |
| 62 | Long-term potentiation_Homo sapiens_hsa04720 | 1.04276502 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03222987 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.00965973 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 1.00646604 |
| 66 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99602272 |
| 67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97656960 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95628662 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.94957424 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.94623231 |
| 71 | Apoptosis_Homo sapiens_hsa04210 | 0.89239749 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88097291 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.87332528 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.87305340 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.86698637 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85596579 |
| 77 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81429088 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.81178724 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.79813231 |
| 80 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76257840 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76229973 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.75801574 |
| 83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75453709 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.74903686 |
| 85 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74423397 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.73806585 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73468872 |
| 88 | * African trypanosomiasis_Homo sapiens_hsa05143 | 0.72089791 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.71731052 |
| 90 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71620767 |
| 91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.71529813 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69647112 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69340384 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.69201970 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.68578761 |
| 96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68046184 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67185119 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65967928 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.65814828 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63073143 |
| 101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62332220 |
| 102 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61677252 |
| 103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.61459294 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61425185 |
| 105 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61137452 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61089072 |
| 107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57533320 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56922810 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55881101 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55599117 |
| 111 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55043362 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54957926 |
| 113 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54787613 |
| 114 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52833324 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50562487 |
| 116 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.50427882 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49406593 |
| 118 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.49321756 |
| 119 | Prion diseases_Homo sapiens_hsa05020 | 0.48972220 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47946443 |
| 121 | GABAergic synapse_Homo sapiens_hsa04727 | 0.47521336 |
| 122 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46434471 |
| 123 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.46075352 |
| 124 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45877239 |
| 125 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45809159 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45681420 |
| 127 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.43868400 |
| 128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43725340 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43157009 |
| 130 | Insulin secretion_Homo sapiens_hsa04911 | 0.42997076 |
| 131 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42852591 |
| 132 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42645385 |
| 133 | Adherens junction_Homo sapiens_hsa04520 | 0.42573896 |
| 134 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.42485825 |
| 135 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42402976 |
| 136 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.42204451 |
| 137 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41958661 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.41842532 |
| 139 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.41714162 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41704628 |
| 141 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40892677 |
| 142 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40193181 |
| 143 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39908431 |
| 144 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.39267104 |
| 145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39222214 |
| 146 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39029620 |
| 147 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.38619069 |
| 148 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38439162 |
| 149 | Morphine addiction_Homo sapiens_hsa05032 | 0.38420026 |
| 150 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37823788 |
| 151 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35136860 |
| 152 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.30689986 |
| 153 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26716386 |
| 154 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.25558608 |
| 155 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.24698847 |
| 156 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24359170 |
| 157 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.23735272 |
| 158 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22882957 |
| 159 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.21322409 |
| 160 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.19665084 |
| 161 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19611098 |
| 162 | Insulin resistance_Homo sapiens_hsa04931 | 0.15800538 |
| 163 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.15594374 |
| 164 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14438422 |
| 165 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11638833 |
| 166 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.08182334 |
| 167 | Endocytosis_Homo sapiens_hsa04144 | 0.07168882 |
| 168 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.05505509 |
| 169 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.00897183 |
| 170 | Prostate cancer_Homo sapiens_hsa05215 | -0.0278696 |
| 171 | Renal cell carcinoma_Homo sapiens_hsa05211 | -0.0056731 |

